Growth Metrics

Ardelyx (ARDX) Non-Current Deffered Revenue (2013 - 2026)

Ardelyx posted quarterly Non-Current Deffered Revenue of $13.7 million for Q1 2026, up 64.06% year-on-year from $8.4 million in Q1 2025, and little changed on a QoQ basis from $13.7 million in Q4 2025.

Ardelyx (ARDX) has 9 years of Non-Current Deffered Revenue data on file, last reported at $13.7 million in Q1 2026.

  • For the quarter ending Q1 2026, Non-Current Deffered Revenue rose 64.06% year-over-year to $13.7 million; the trailing twelve-month figure through Mar 2026 stood at $13.7 million (up 64.06% YoY), and the FY2025 full-year result was $13.7 million, up 89.42% from the prior year.
  • Non-Current Deffered Revenue for Q1 2026 stood at $13.7 million, roughly flat from $13.7 million in the prior quarter.
  • Across five years, Non-Current Deffered Revenue topped out at $13.7 million in Q3 2025 and bottomed at $7.2 million in Q4 2024.
  • The 5-year median for Non-Current Deffered Revenue is $10.3 million (2023), against an average of $10.7 million.
  • The widest annual swing landed in 2022, when Non-Current Deffered Revenue soared 321.48%; it then tumbled 31.01% in 2025.
  • A 5-year view of Non-Current Deffered Revenue shows it stood at $9.0 million in 2022, then fell by 4.22% to $8.6 million in 2023, then declined by 16.34% to $7.2 million in 2024, then jumped by 89.42% to $13.7 million in 2025, then changed by 0.0% to $13.7 million in 2026.
  • The last three Non-Current Deffered Revenue figures came in at $13.7 million (Q1 2026), $13.7 million (Q4 2025), and $13.7 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Deffered Revenue (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn - -
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn - -
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn -
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn - -
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn - -
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn -
7 Evaxion A 64.16 Bn 64.14 Bn - -
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn 225.10 Mn
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn -
10 Ardelyx 1.48 Bn 1.25 Bn 89.66 Mn 13.70 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 13.70 Mn
Dec 31, 2025 13.70 Mn
Sep 30, 2025 13.70 Mn
Jun 30, 2025 12.30 Mn
Mar 31, 2025 8.35 Mn
Dec 31, 2024 7.23 Mn
Sep 30, 2024 12.77 Mn
Jun 30, 2024 9.61 Mn
Mar 31, 2024 12.10 Mn
Dec 31, 2023 8.64 Mn
Sep 30, 2023 10.29 Mn
Jun 30, 2023 9.24 Mn
Mar 31, 2023 11.50 Mn
Dec 31, 2022 9.03 Mn
Sep 30, 2022 8.56 Mn
Jun 30, 2022 12.42 Mn
Mar 31, 2022 8.56 Mn
Dec 31, 2021 4.73 Mn
Sep 30, 2021 2.95 Mn
Jun 30, 2021 2.95 Mn
Mar 31, 2021 2.95 Mn
Mar 31, 2015 27.19 Mn
Dec 31, 2014 31.07 Mn
Sep 30, 2014 34.96 Mn
Jun 30, 2014 33.17 Mn
Dec 31, 2013 26.47 Mn